Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1979-11-21
pubmed:keyword
http://linkedlifedata.com/resource/pubmed/keyword/Biology, http://linkedlifedata.com/resource/pubmed/keyword/Clinical Research, http://linkedlifedata.com/resource/pubmed/keyword/Contraception, http://linkedlifedata.com/resource/pubmed/keyword/Contraceptive Agents..., http://linkedlifedata.com/resource/pubmed/keyword/Contraceptive Agents..., http://linkedlifedata.com/resource/pubmed/keyword/Contraceptive Agents..., http://linkedlifedata.com/resource/pubmed/keyword/Contraceptive Agents--analysis, http://linkedlifedata.com/resource/pubmed/keyword/Contraceptive..., http://linkedlifedata.com/resource/pubmed/keyword/Endocrine System, http://linkedlifedata.com/resource/pubmed/keyword/Estradiol--analysis, http://linkedlifedata.com/resource/pubmed/keyword/Estrogens, http://linkedlifedata.com/resource/pubmed/keyword/Ethinyl Estradiol--analysis, http://linkedlifedata.com/resource/pubmed/keyword/Family Planning, http://linkedlifedata.com/resource/pubmed/keyword/Follicle Stimulating..., http://linkedlifedata.com/resource/pubmed/keyword/Gonadotropins, http://linkedlifedata.com/resource/pubmed/keyword/Gonadotropins, Pituitary, http://linkedlifedata.com/resource/pubmed/keyword/Hormones, http://linkedlifedata.com/resource/pubmed/keyword/Human Volunteers, http://linkedlifedata.com/resource/pubmed/keyword/Levonorgestrel--analysis, http://linkedlifedata.com/resource/pubmed/keyword/Luteinizing Hormone--analysis, http://linkedlifedata.com/resource/pubmed/keyword/Oral Contraceptives..., http://linkedlifedata.com/resource/pubmed/keyword/Oral..., http://linkedlifedata.com/resource/pubmed/keyword/Physiology, http://linkedlifedata.com/resource/pubmed/keyword/Progestational Hormones, http://linkedlifedata.com/resource/pubmed/keyword/Progesterone--analysis, http://linkedlifedata.com/resource/pubmed/keyword/Research Methodology
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0010-7824
pubmed:author
pubmed:issnType
Print
pubmed:volume
20
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
61-9
pubmed:dateRevised
2004-11-17
pubmed:otherAbstract
PIP: The effects of deliberate omission of a Microgynon 30 (150 mcg of levonorgestrel and 30 mcg of ethinyl estradiol) tablet in the early and latter course of the pills were investigated by hormonal profiles (published figuratively) of luteinizing hormone, follicle stimulating hormone (FSH), estradiol 17-beta, and progesterone. 3 women deliberately missed Day 19, and blood samples were drawn from Day 17-24; 7 women deliberately omitted Day 4 treatment, and their blood was drawn from Day 1-7. Blood levels, contrary to previous findings which noted a sharp rise in FSH and near zero titers of steroids after omission of a Microgynon 30 tablet unintentionally, did not show any marked rise either early or late in the cycle omission. Cervical mucus examined in 6 of the subjects displayed physical characteristics associated with an uninterrupted ancillary contraceptive effect.
pubmed:meshHeading
pubmed:year
1979
pubmed:articleTitle
Studies on low dose oral contraceptives: plasma hormone changes in relation to deliberate pill ('Microgynon 30') omission.
pubmed:publicationType
Journal Article